BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 22712479)

  • 21. Diagnosis of metastases from postoperative differentiated thyroid cancer: comparison between FDG and FLT PET/CT studies.
    Nakajo M; Nakajo M; Jinguji M; Tani A; Kajiya Y; Tanabe H; Fukukura Y; Nakabeppu Y; Koriyama C
    Radiology; 2013 Jun; 267(3):891-901. PubMed ID: 23468571
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical impact of 18F-FDG-PET in the suspicion of recurrent colorectal cancer based on asymptomatically elevated serum level of carcinoembryonic antigen (CEA) in Taiwan.
    Shen YY; Liang JA; Chen YK; Tsai CY; Kao CH
    Hepatogastroenterology; 2006; 53(69):348-50. PubMed ID: 16795969
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of FDG-PET, PET/CT and MRI for follow-up of colorectal liver metastases treated with radiofrequency ablation: initial results.
    Kuehl H; Antoch G; Stergar H; Veit-Haibach P; Rosenbaum-Krumme S; Vogt F; Frilling A; Barkhausen J; Bockisch A
    Eur J Radiol; 2008 Aug; 67(2):362-371. PubMed ID: 18155866
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [18F]Fluorodeoxyglucose PET for Interventional Oncology in Liver Malignancy.
    Samim M; El-Haddad GE; Molenaar IQ; Prevoo W; van den Bosch MA; Alavi A; Lam MG
    PET Clin; 2014 Oct; 9(4):469-95, vi. PubMed ID: 26050948
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Dual-time point images of the liver with (18)F-FDG PET/CT in suspected recurrence from colorectal cancer].
    Fuster D; Lafuente S; Setoain X; Navales I; Perissinotti A; Pavia J; Paredes P; LomeƱa F; Pons F
    Rev Esp Med Nucl Imagen Mol; 2012; 31(3):111-6. PubMed ID: 22154291
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detection of residual tumor following radiofrequency ablation of liver metastases using 18F-FDG PET/PET-CT: a systematic review and meta-analysis.
    Zheng JH; Chang ZH; Han CB; Ma JT; Liu ZY; Lu ZM; Guo QY
    Nucl Med Commun; 2014 Apr; 35(4):339-46. PubMed ID: 24323312
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PET/CT pattern analysis for surgical staple line recurrence in patients with colorectal cancer.
    Shyn PB; Madan R; Wu C; Erturk SM; Silverman SG
    AJR Am J Roentgenol; 2010 Feb; 194(2):414-21. PubMed ID: 20093604
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predictive value of pattern classification 24 hours after radiofrequency ablation of liver metastases on CT and positron emission tomography/CT.
    Vandenbroucke F; Vandemeulebroucke J; Ilsen B; Verdries D; Belsack D; Everaert H; Buls N; Ros PR; de Mey J
    J Vasc Interv Radiol; 2014 Aug; 25(8):1240-9. PubMed ID: 24954606
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The economic impact of 18FDG positron emission tomography in the surgical management of colorectal cancer with hepatic metastases.
    Zubeldia JM; Bednarczyk EM; Baker JG; Nabi HA
    Cancer Biother Radiopharm; 2005 Aug; 20(4):450-6. PubMed ID: 16114993
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessment of tumor recurrence in patients with colorectal cancer and elevated carcinoembryonic antigen level: FDG PET/CT versus contrast-enhanced 64-MDCT of the chest and abdomen.
    Metser U; You J; McSweeney S; Freeman M; Hendler A
    AJR Am J Roentgenol; 2010 Mar; 194(3):766-71. PubMed ID: 20173157
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Can (18)F-FDG PET/CT scan change treatment planning and be prognostic in recurrent colorectal carcinoma? A prospective and follow-up study.
    Artiko V; Odalovic S; Sobic-Saranovic D; Petrovic M; Stojiljkovic M; Petrovic N; Kozarevic N; Grozdic-Milojevic I; Obradovic V
    Hell J Nucl Med; 2015; 18(1):35-41. PubMed ID: 25840571
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical utility of F-18 FDG PET/CT in recurrent breast carcinoma.
    Manohar K; Mittal BR; Senthil R; Kashyap R; Bhattacharya A; Singh G
    Nucl Med Commun; 2012 Jun; 33(6):591-6. PubMed ID: 22334135
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Selection of patients for resection of hepatic metastases: improved detection of extrahepatic disease with FDG pet.
    Zealley IA; Skehan SJ; Rawlinson J; Coates G; Nahmias C; Somers S
    Radiographics; 2001 Oct; 21 Spec No():S55-69. PubMed ID: 11598248
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of FDG-PET, MRI and CT for post radiofrequency ablation evaluation of hepatic tumors.
    Chen W; Zhuang H; Cheng G; Torigian DA; Alavi A
    Ann Nucl Med; 2013 Jan; 27(1):58-64. PubMed ID: 23054830
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 18F-FDG PET/CT in evaluation of radiofrequency ablation of liver metastasis.
    Thulkar S; Chawla M; Sharma P; Malhotra A; Kumar R
    Clin Nucl Med; 2012 May; 37(5):498-501. PubMed ID: 22475904
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The utility of PET/CT in the management of patients with colorectal liver metastases undergoing laparascopic radiofrequency thermal ablation.
    Sahin DA; Agcaoglu O; Chretien C; Siperstein A; Berber E
    Ann Surg Oncol; 2012 Mar; 19(3):850-5. PubMed ID: 21913009
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Detection of residual tumor after radiofrequency ablation of liver metastasis with dual-modality PET/CT: initial results.
    Veit P; Antoch G; Stergar H; Bockisch A; Forsting M; Kuehl H
    Eur Radiol; 2006 Jan; 16(1):80-7. PubMed ID: 15868122
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Maximum standardized uptake value is more reliable than size measurement in early follow-up to evaluate potential pulmonary malignancies following radiofrequency ablation.
    Alafate A; Shinya T; Okumura Y; Sato S; Hiraki T; Ishii H; Gobara H; Kato K; Fujiwara T; Miyoshi S; Kaji M; Kanazawa S
    Acta Med Okayama; 2013; 67(2):105-12. PubMed ID: 23603927
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 18F-FDG PET/CT Is an Immediate Imaging Biomarker of Treatment Success After Liver Metastasis Ablation.
    Cornelis F; Sotirchos V; Violari E; Sofocleous CT; Schoder H; Durack JC; Siegelbaum RH; Maybody M; Humm J; Solomon SB
    J Nucl Med; 2016 Jul; 57(7):1052-7. PubMed ID: 26912433
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Detection of recurrent and metastatic colorectal cancer: comparison of positron emission tomography and computed tomography.
    Ogunbiyi OA; Flanagan FL; Dehdashti F; Siegel BA; Trask DD; Birnbaum EH; Fleshman JW; Read TE; Philpott GW; Kodner IJ
    Ann Surg Oncol; 1997 Dec; 4(8):613-20. PubMed ID: 9416407
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.